DDF Group companies
The DDF group consists of three synergistic organizations that actively support each other. The synergy of the group companies helps to make DDF a platform that makes a difference in bringing life science innovations to patients.
DDF Ventures is supporting a portfolio of five promising early stage life science companies. Portfolio company activities range from anti-cancer drug development, to immunology platform technology, transdermal microneedle based drug delivery and dietary supplements.
Catalyze is a fast growing organization working with European life science companies to secure non-dilutive grant or loan funding. The teams at Catalyze will also help to build the right consortia, not only for funding, but also for efficient collaborations.
Julius Clinical is a world wide operating Clinical Research Organization, used to organize and run large Phase III trials for pharma companies, but also with th flexibility and experience to do innovatively designed Phase II trials for small biotech companies.